Comparison of donor versus no donor in 3 cytogenetic groups and the 3 age groups according to different endpoints
. | Disease-free survival . | Time to relapse . | Time to death in CR . | Survival . |
|---|---|---|---|---|
| Cytogenetic groups | ||||
| Good | 1.21 (0.66, 2.25) | 0.83 (0.38, 1.78) | 3.03 (0.91, 10.06) | 1.41 (0.70, 2.82) |
| Intermediate | 1.16 (0.75, 1.81) | 0.84 (0.50, 1.41) | 4.06 (1.41, 11.68) | 1.14 (0.70, 1.86) |
| Bad/very bad | 0.58 (0.39, 0.87) | 0.42 (0.26, 0.68) | 2.70 (0.93, 7.80) | 0.62 (0.40, 0.96) |
| Age groups | ||||
| 15-25 y | 0.65 (0.41, 1.04) | 0.53 (0.32, 0.89) | 2.28 (0.64, 8.10) | 0.63 (0.37, 1.07) |
| 26-35 y | 0.69 (0.46, 1.02) | 0.48 (0.30, 0.77) | 2.63 (1.08, 6.40) | 0.70 (0.45, 1.08) |
| 36-45 y | 0.97 (0.70, 1.33) | 0.65 (0.44, 0.95) | 3.91 (1.83, 8.34) | 1.09 (0.78, 1.54) |
. | Disease-free survival . | Time to relapse . | Time to death in CR . | Survival . |
|---|---|---|---|---|
| Cytogenetic groups | ||||
| Good | 1.21 (0.66, 2.25) | 0.83 (0.38, 1.78) | 3.03 (0.91, 10.06) | 1.41 (0.70, 2.82) |
| Intermediate | 1.16 (0.75, 1.81) | 0.84 (0.50, 1.41) | 4.06 (1.41, 11.68) | 1.14 (0.70, 1.86) |
| Bad/very bad | 0.58 (0.39, 0.87) | 0.42 (0.26, 0.68) | 2.70 (0.93, 7.80) | 0.62 (0.40, 0.96) |
| Age groups | ||||
| 15-25 y | 0.65 (0.41, 1.04) | 0.53 (0.32, 0.89) | 2.28 (0.64, 8.10) | 0.63 (0.37, 1.07) |
| 26-35 y | 0.69 (0.46, 1.02) | 0.48 (0.30, 0.77) | 2.63 (1.08, 6.40) | 0.70 (0.45, 1.08) |
| 36-45 y | 0.97 (0.70, 1.33) | 0.65 (0.44, 0.95) | 3.91 (1.83, 8.34) | 1.09 (0.78, 1.54) |
Numbers are shown as estimated hazard ratio (95% CI).